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Abstract

Institutional animal care and use committee statement: All
procedures involving animals were reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC) of the
University of Cincinnati (protocol number: 06-06-22-02).

AIM: To investigate the intestinal functions of the NKCC1
+
+
Na -K -2Cl cotransporter (SLC12a2 gene), differential
mRNA expression changes in NKCC1-null intestine were
analyzed.

Conflict-of-interest statement: The authors have no conflict of
interest related to this manuscript.

METHODS: Microarray analysis of mRNA from intestines
of adult wild-type mice and gene-targeted NKCC1null mice (n = 6 of each genotype) was performed to
identify patterns of differential gene expression changes.
Differential expression patterns were further examined
by Gene Ontology analysis using the online Gorilla
program, and expression changes of selected genes were
verified using northern blot analysis and quantitative
real time-polymerase chain reaction. Histological staining
and immunofluorescence were performed to identify cell
types in which upregulated pancreatic digestive enzymes
were expressed.

Data sharing statement: The microarray data have been
deposited in the National Center for Biotechnology Gene
Expression Omnibus and can be freely accessed as described in
Methods. The Slc12a2 (NKCC1) knockout mouse model has
been deposited in a publically available repository and can be
accessed as described in Methods.
Open-Access: This article is an open-access article which was
selected by an in-house editor and fully peer-reviewed by external
reviewers. It is distributed in accordance with the Creative
Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this
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RESULTS: Genes typically associated with pancreatic
function were upregulated. These included lipase,
amylase, elastase, and serine proteases indicative of
pancreatic exocrine function, as well as insulin and
regenerating islet genes, representative of endocrine
function. Northern blot analysis and immunohistoche
mistry showed that differential expression of exocrine
pancreas mRNAs was specific to the duodenum and
localized to a subset of goblet cells. In addition, a major
pattern of changes involving differential expression of
olfactory receptors that function in chemical sensing, as
well as other chemosensing G-protein coupled receptors,
was observed. These changes in chemosensory receptor
expression may be related to the failure of intestinal
function and dependency on parenteral nutrition
observed in humans with SLC12a2 mutations.

through the apical cystic fibrosis transmembrane con
ductance regulator (CFTR). In addition to secretory
epithelia, NKCC1 is expressed in all segments of the
gastrointestinal tract and throughout the crypt and
villus epithelium, including both absorptive cells and
[1]
goblet cells . Thus, loss or inhibition of NKCC1 could
have wide-ranging effects on gastrointestinal function.
In fact, a National Institutes of Health web site (http://
www.genome.gov/27551936) on Rare or Undiagnosed
Diseases reports that humans with SLC12A2 mutations
have “exercise intolerance, dilated cardiomyopathy,
and episodic hypoglycemia progressing to unexplained
failure of intestinal function/food tolerance with sub
sequent parenteral nutrition dependency”. The basis
for the severe intestinal phenotype in humans is not
known, but since it does not mimic the Cystic Fibrosis
intestinal phenotype, it is unlikely to be due entirely to
the secretory defect.
When anion secretion is impaired, the intestinal
lumen can become desiccated, which leads to consti
pation, obstructions, and intussusception. Mice lacking
CFTR usually develop lethal intestinal obstructions
by 6 wk of age and require treatment with an osmo
[2]
tic laxative for normal survival , but the intestinal
-/[3]
phenotype of Nkcc1 mice is much less severe . In the
-/original study, a small percentage of the Nkcc1 mice
on a mixed genetic background developed intestinal
[3]
-/impactions . However, Nkcc1 mice on the FVB/N
background (Swiss mice carrying the Fv1b sensitizing
allele) that were used for the current study do not
develop impactions, and the intestinal tract appears
histologically normal.
Loss of NKCC1 in mice causes a defect in intestinal
anion secretion as measured by reductions in the
bumetanide-sensitive component in short circuit currents
[3-5]
in duodenum, jejunum, and cecum . However, com
pensatory pathways for basolateral Cl uptake have
[5,6]
been identified in duodenum and colon , providing an
explanation of why the loss of NKCC1 does not cause a
profound defect in anion secretion in the intestinal tract.
To gain a better understanding of the functions of NKCC1
and the molecular consequences of NKCC1-deficiency
in the intestine, we performed microarray analyses
-/of mRNA from Nkcc1 small intestine. The observed
alterations in the expression of mRNAs encoding
digestive enzymes and receptors that mediate chemical
sensing could be involved in intestinal pathologies
resulting from the inhibition or loss of NKCC1.

CONCLUSION: The results suggest that loss of NKCC1
affects not only secretion, but also goblet cell function
and chemosensing of intestinal contents via G-protein
coupled chemosensory receptors.
Key words: SLC12a2 ; Chemosensory; Chemosensitivity;
Gastrointestinal; Dyspepsia
© The Author(s) 2016. Published by Baishideng Publishing
Group Inc. All rights reserved.

Core tip: The NKCC1 Na+-K+-2Cl- cotransporter is a
major mechanism of Cl uptake in support of secretion.
To investigate its intestinal functions we analyzed mRNA
expression changes in NKCC1-null intestines. Differ
entially expressed genes included digestive enzymes
and a large number of olfactory and other G-protein
coupled receptors that function in chemical sensing. This
suggests that loss of NKCC1 affects not only secretion,
but also digestion and chemosensing of components
of the intestinal contents. The results likely have relev
ance to recent evidence showing that mutations in the
human NKCC1 gene cause unexplained food intolerance
and failure of intestinal function requiring parenteral
nutrition.
Bradford EM, Vairamani K, Shull GE. Differential expression of
pancreatic protein and chemosensing receptor mRNAs in NKCC1null intestine. World J Gastrointest Pathophysiol 2016; 7(1):
138-149 Available from: URL: http://www.wjgnet.com/2150-5330/
full/v7/i1/138.htm DOI: http://dx.doi.org/10.4291/wjgp.v7.i1.138

MATERIALS AND METHODS

INTRODUCTION
+

+

NKCC1-null mutant mouse model
-/-

-

WJGP|www.wjgnet.com

[3]

Nkcc1 mice were generated as previously described
and inbred onto the FVB/N background for at least 10
generations. FVB/N are Swiss mice, derived from the
HFSF/N strain, which carry the Fv1b (Friend Leukemia
-/Virus strain B) sensitizing allele. These Nkcc1 mice are
available from the Jackson Labs Mutant Mouse Regional
Resource Center and can be identified by searching

The NKCC1 Na -K -2Cl cotransporter, encoded by the
SLC12A2 gene, is expressed in all mammalian tissues
and is particularly prominent in epithelial cells of the
[1]
gastrointestinal tract . Detailed immunohistoche
mical studies show that it is localized to basolateral
[1]
membranes of intestinal secretory epithelia , where it
mediates uptake of much of the Cl that is then secreted
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(PCR), 4 μg of total RNA was reversed transcribed using
oligo d(T) and SuperScript Ⅱ reverse transcriptase
(Invitrogen). The cDNA was diluted 5-fold in water.
Primer sequences are given in Table 1. For each primer
set, optimization using serially-diluted standards and
melting curve analysis was performed. Real-time PCR
was run on a DNA Engine Opticon Ⅱ (MJ Research)
thermalcycler using iQ SYBR Green (BioRad). For each
gene, samples were run at least in duplicate, and
mean values were normalized to the expression of
L32. Standard curves were prepared for each gene on
every run. All pairwise comparisons were done using
a student’s t-test; P-values of < 0.05 were considered
significant.

Table 1 Primer sequences used for quantitative real-time
polymerase chain reaction and northern blot analyses
Name

Sequence

Pdx1

F: ACCAAAGCTCACGCGTGGAAA
R: TGATGTGTCTCTCGGTCAAGTT
F: TTGCCCTCTGGGAGCCCAAA
R: CAGATGCTGGTGCAGCACTG
F: TCTTCCTCTGGGAGTCCCAC
R: CAGATGCTGGTGCAGCACTG
F: CATTGCTGGAAGAAGCGTATCAG
R: GAGACCTTCTGCTCAGTCGACG
F: TTAACGATAATAAATGTAATGGAGAA
R: CCCTGCTACTCCAATGTCAA
F: TGAGCAGTTTGTCAATTCTGCC
R: GCATGATGTCGTTGTTCAGGG
F: GTAGTTGCAGCCCAGAGAGG
R: TCTGCTATGTCACAGGCTGG
F: TCCCTGCCAGAATCACACGGT
R: GGAGGTCCTGCCTACAGACACA
F: GATCTAGCGGCCGCCATCTGTTTACGGCATCATG
R: TAGATCGCGGCCGCCGCTCCCATAACCGATGTTGG

Insulin 1
Insulin 2
Glut2
Amylase
Trypsin
Elastase
Gp2
L32

Morphology and immunofluorescence

Intestinal segments were fixed in 10% neutral buffered
formalin overnight and embedded in paraffin. Goblet
cells were identified with hemotoxylin and eosin (H and
E) or Alcian Blue/Periodic Acid-Schiff (AB/PAS) staining
[8]
as described previously . For immunofluorescence,
sections (n = 4 WT and 3 NKCC1-null mutant) were
deparaffinized in Citrisolve, rehydrated through succe
ssive ethanol washes, and boiled for 5 min in a sodium
citrate buffer. Sections were incubated with primary
antibodies for 12 h at room temperature, washed,
and incubated with either another primary antibody
or the appropriate secondary antibodies for 12 h
at room temperature. Polyclonal antibodies against
amylase (Sigma), trypsin (Abcam), elastase (Abcam),
and intestinal trefoil factor 3 (TFF3) (ITF-Santa Cruz
Biotechnology) were used at a 1:100 dilution; all
secondary antibodies (Alexa Fluor, Molecular Probes)
were used at a 1:200 dilution, and DAPI was included in
the mounting medium (Vector Laboratories) for staining
of nuclei. For localization studies using both fluorescence
and AB/PAS, immunohistochemistry was done first and
the slides were photographed. The slides were then
washed, AB/PAS staining was performed, and the same
areas were imaged. For colocalization studies, images
were merged in Adobe Photoshop.

Forward and reverse primers for quantitative real-time polymerase chain
reaction and northern blot probes are listed 5’ to 3’.

(http://www.jax.org/mmrrc/) with the gene symbol
Slc12a2 (strain name: FVB.Cg-Slc12a2tm1Ges). Wildtype (WT) FVB/N mice were originally obtained from
Jackson Labs and bred in house. All experimental pairs
were derived by breeding of NKCC1 heterozygous
breeding pairs, were between 8 and 12 wk of age,
and were age- and gender-matched. Mouse numbers
(n) are indicated in methods or figure legends. Mice
were maintained in a specific pathogen-free barrier
facility, with access to food and water ad libitum, and
all experiments were approved by the University of
Cincinnati Animal Care and Use Committee.

Isolation of intestinal tissues

Mice were anesthetized by intraperitoneal injection
of Avertin (2.5% solution of Tribromethanol) at 500
mg/kg, followed by cervical dislocation after the mice
were anesthetized. Intestinal segments were removed
and flushed with ice-cold phosphate-buffered saline.
Some samples were frozen in liquid nitrogen and used
for extraction of total RNA using Tri-Reagent (Molecular
Research Center) and others were processed for
immunolocalization studies as described in detail below.

Microarray analysis

Microarray analyses were performed by the University
of Cincinnati Genomics and Microarray Laboratory core
[8]
facility exactly as described previously using the Duke
University Murine Operon v.3.0 spotted Array, which
consisted of the Operon mouse oligonucleotide library,
version 3.0, comprised of 70-mer oligonucleotides
representing mouse genes. For analysis of NKCC1-null
small intestine, total RNA was isolated from the entire
small intestine of 8-wk old WT and NKCC1-null mutant
(KO) mice (n = 6 of each genotype) on the FVB/N
background, and cDNA was generated and labeled
with Cy3 or Cy5 fluorophores and hybridized with the
microarrays. The fold-changes and statistical significance
for the microarray analysis were calculated exactly as
[8]
described previously . Briefly, Cy3 and Cy5 labeling

Northern blot analysis and real-time polymerase chain
reaction

Northern blot analysis was performed using 10 mg of
total RNA per sample, and blots were hybridized with
32
[7]
P-labeled cDNA as previously described . Primer
sequences are given in Table 1. Quantification of
band intensity, including background subtraction and
normalization to the ribosomal L32 subunit mRNA,
was done using ImageQuant software (Amersham
Biosciences).
For quantitative real-time polymerase chain reaction

WJGP|www.wjgnet.com
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was alternated between WT and KO samples (dyeflip controls) to control for the influence of fluorophore
labeling on probe hybridization. Values are represented
as fold-changes (ratio of fluorescence intensity values),
with positive values indicating upregulation and negative
values indication downregulation in KO relative to WT.
The complete set of microarray data as well a list of
the significantly changed genes and more detailed
methods have been deposited in the National Center for
Biotechnology Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/) and are available through
GEO accession number GSE19117. The statistical
analysis of the data has been reviewed by Dr. Mario
Medvedovic, Director of the Division of Biostatistics and
Bioinformatics, Department of Environmental Health,
University of Cincinnati.

genes exhibiting differential expression in the Nkcc1-null
intestine, all were upregulated, with induction ranging
from 3.5-fold to 15.8-fold (Table 2). A pattern of
genes typically associated with the exocrine pancreas,
namely the digestive enzymes and components of the
zymogen granules, was immediately apparent. Cpa1
is a pancreatic carboxypeptidase that was upregulated
15.8-fold. Elastases 1, 2, and 3B were all up-regulated
and exhibited high fluorescence intensities. Several
serine proteases, including trypsins 1, 2, 4, and 10, as
well as chymotrypsins A, B and C, were also up-regu
lated. Amylase, another digestive enzyme produced by
the pancreas, was increased 8.7-fold. Besides digestive
enzymes, a number of the highly upregulated genes
encode proteins that are associated with zymogen
granules (see Discussion). These included glycoprotein
2 (Gp2, 3.9-fold), pancreatic protein disulfide isomerase
(Pdia2, 4.5-fold), and syncollin (Sycn, 3.0-fold; P <
0.001, data not shown).
In addition to enzymes typical of the exocrine pan
creas, genes commonly expressed in the endocrine
pancreas were also upregulated. These included Reg1
and Reg2 (regenerating islet or pancreatic stone
[10]
proteins) , which were upregulated 4.6- and 3.6-fold
(Table 2), insulin 1 (Ins1, 1.92-fold; P < 0.003), and
pancreatic-duodenal homeobox 1 (Pdx1; 2.53-fold,
P < 0.002), which is heavily involved in regulation of
[11]
β-cell function . Glut2, which is the most abundant
[12]
facilitative glucose transporter in the intestine , was
also upregulated (1.65-fold, P < 0.007).
Northern blot analysis and quantitative RT-PCR of
several genes validated the results of the microarray
analysis (Figure 1). The expression of elastase (4.7-fold),
amylase (1.9-fold), glycoprotein 2 (3.4-fold), and
trypsin (6.0-fold) were all significantly up-regulated in
the duodenum (Figure 1A and B). The Northern blot
data indicated that the up-regulation of these genes
-/observed in microarray analyses of the Nkcc1 small
intestine occurs primarily in the duodenum. It should be
noted that expression of these genes in the duodenum
appeared to be robust and did not require long exposure
times to be detected, even in the WT samples. RT-PCR
confirmed upregulation of Pdx1, Ins1, and Glut2 in the
-/Nkcc1 small intestine (Figure 1C).

Gene Ontology analysis

Gene Onlology analysis was performed using the
[9]
online GOrilla program (Gene Ontology enRIchment
anaLysis and visuaLizAtion tool) (http://cbl-gorilla.
cs.technion.ac.il/). Two analysis options were used:
(1) Single Rank List, with the entire gene set ranked
according to P values; and (2) Two Unranked Lists, in
which a target list of genes with a specific range of P
values is compared against the list of all genes analyzed
(13551 total). The Single Rank option avoids setting an
arbitrary cutoff of P values and was useful for identifying
GO categories that were highly enriched at the top
end of the significance range. In the Two List analysis,
significance and enrichment was calculated based on
the number of genes in each GO category that appear
in the target list and background list. Enrichment (N, B,
n, b) is defined as: N is the total number of genes, B is
the total number of genes associated with a specific GO
term, n is the number of genes in the top of the user’s
input list or in the target set when appropriate, b is the
number of genes in the intersection; Enrichment = (b/
n)/(B/N). The program calculates statistical probabilities
[9]
using the hypergeometric distribution .

Expression atlas data

RNA Seq mRNA expression data for human duodenum
and pancreas was obtained from the European Bioin
formatics Institute (EBI) Expression Atlas (http://
www.ebi.ac.uk/gxa/home). This data base allowed
an evaluation of the relative expression levels of the
various pancreatic genes that were upregulated in the
-/duodenum of Nkcc1 mice. The data were available
through baseline experiments, Uhlen’s lab, in which 32
human tissues are represented.

Morphology of the NKCC1-deficient gastrointestinal
tract

In previous studies the stomach, intestine, liver, and pan
-/[3]
creas of Nkcc1 mice appeared histologically normal ,
and no apparent differences in the morphology of the
gastrointestinal tract was observed in the current study.
Based on the results of the microarray analysis and
histology, it is evident that the basic population of cells
-/in the intestine of the Nkcc1 mice is not significantly
altered. Expression of the Paneth cell markers matrix
metalloproteinase 7 and lysozyme were not significantly
changed, and neither were the expression of the major
goblet cell markers mucin 2 and TFF3. The expression

RESULTS
Upregulation of pancreatic genes in NKCC1-null small
intestine

Microarray analysis was performed using small intestine
-/RNA from the Nkcc1 and WT mice. Among the top 30

WJGP|www.wjgnet.com
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Table 2 Genes with the highest levels of differential expression in the Nkcc1 -null intestine
Gene symbol
Cpa1
Elane
Glb1l3
Try4
Rnase1
Cpb1
Amy2a5
Try10
Ctrc
Ctrb1
Pnlip
Prss1
Cel
Cela3b
Prss2
Pnliprp1
Muc6
Tff2
Cela1
V1rh10
Calb3
Reg1
Pdia2
Akp3
Gp2
Cep350
Bmper
Olfr846
Reg2
Ctrl

Description

Average intensity

Fold change

Carboxypeptidase A1, pancreatic
Elastase 2
Galactosidase, beta 1 like 3
Trypsin 4
Ribonuclease 1, pancreatic RNase A
Carboxypeptidase B1
Amylase 2, pancreatic
Trypsin 10
Chymotrypsin C (caldecrin)
Chymotrypsinogen B1
Pancreatic lipase
Protease, serine 1 (trypsin 1)
Bile salt activated lipase, pancreatic
Elastase 3B, pancreatic
Protease, serine 2 (trypsin II)
Pancreatic lipase related protein 1
Mucin 6, gastric
Trefoil factor 2
Elastase 1, pancreatic
Vomeronasal 1 receptor, H10
Calbindin D9K
Lithostathine 1 (pancreatic stone protein 1)
Protein disulfide isomerase, pancreatic
Alkaline phosphatase 3, intestine
Glycoprotein 2 (zymogen granule membrane)
Centrosomal protein 350
BMP-binding endothelial regulator
Olfactory receptor 846
Lithostathine 2 (pancreatic stone protein 2)
Chymotrypsin like; chymotrypsin A

1811
2118
234
2251
592
866
691
2306
397
3360
1938
1481
356
1576
716
574
152
1391
549
107
609
5648
292
366
377
141
318
432
253
1431

15.86
12.05
10.27
9.91
9.28
9.15
8.75
8.33
7.79
7.66
7.24
6.93
6.73
6.69
6.52
5.83
5.78
5.77
4.84
4.66
4.64
4.56
4.47
4.02
3.92
3.92
3.78
3.66
3.58
3.49

P value
0.00001
0.00001
0.0001
0.00001
0.00001
0.00001
0.00001
0.00001
0.0003
0.00001
0.00001
0.00001
0.00001
0.00001
0.0001
0.0001
0.0053
0.0200
0.0002
0.0008
0.00001
0.0008
0.0004
0.00001
0.0001
0.0003
0.0011
0.0001
0.0383
0.0030

Differential expression is presented as fold-changes in Nkcc1-/- intestine relative to wild-type intestine. Average intensity (average of Cy3 and Cy5
fluorescence intensities) is roughly indicative of relative expression levels. P values are less than or equal to the numbers shown.

of sucrase-isomaltase (alpha glucosidase), associated
with terminally-differentiated enterocytes, was also not
significantly different. Collectively, these data support
the histological assessment that the basic structure and
cell populations in the gut of the mutant mice are not
significantly changed.

lase in cells that were also stained with AB/PAS provided
further evidence that expression was occurring in a
subset of goblet cells, as there were AB/PAS-positive
goblet cells that lacked amylase (Figure 3). In some
cases, it was possible to identify an amylase or elastasepositive cloud or cap over the lumenal border of the
cells, and above the mucus, suggesting that these
proteins are secreted from a separate compartment, or
from separate granules, than TFF3-labeled mucins.

Immunolocalization of pancreatic enzymes in the
duodenum

Immunofluorescence of amylase, trypsin, and elastase
identified cytoplasmic staining of a subset of cells in
the crypts and along the villi. Morphologically, these
cells were clearly goblet cells. Co-immunofluorescence
experiments using an antibody against intestinal TFF3,
which is a goblet-cell specific marker, demonstrated
that amylase, elastase and trypsin co-localize with Tff3
in goblet cells (Figure 2). Although mucus is known to
bind antibodies non-specifically, in sections containing
only the primary or secondary antibody, the goblet cells
excluded all background fluorescence, indicating that
the staining for each antibody was specific.
Interestingly, all amylase-positive cells contained
TFF3; however, not all TFF3-positive cells were amylasepositive. This indicates that only a subset of goblet
cells produce pancreatic-type peptidases and auxiliary
zymogen granule proteins. Immunolocalization of amy

WJGP|www.wjgnet.com

Gene Ontology analysis of differentially expressed
genes in Nkcc1-/- intestine

The differentially expressed genes were subjected
to Gene Ontology analysis using the online GOrilla
[9]
program , and significant GO categories were identified
(Table 3). Using the single rank option (see Methods),
the GO categories included those dealing with digestion
and closely related protease and triglyceride lipase
activities, which were highly enriched in the top end
of the significance range. Sensory perception and the
closely related olfactory receptor/G-protein coupled
receptor activities were also enriched using the single
rank option; these categories included genes spanning
a much greater significance range; this was particularly
apparent for olfactory receptor activities. Similar
results were obtained using the two list option and a
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A

Jejunum

Duodenum
WT

KO

WT

KO

WT

KO

WT

KO

WT

Ileum

KO

WT

KO

WT

KO

WT

KO

WT

KO

Ela

Gp2

Try

L32

B

WT

KO

WT

KO

WT

KO

WT

KO

C

15
b

Rclative fold change

Ela

Gp2

Try

10

5

a
a

L32

0
Pdx1

Ins1

Glut2

Figure 1 Northern blot and polymerase chain reaction analysis of duodenal gene expression. A: Northern blots show upregulation of Ela, Gp2, and Try
primarily in the duodenum of Nkcc1-/- (KO) mice relative to WT; n = 3 WT and 3 KO for each segment; B: Duodenal tissue from a separate cohort of mice confirms
upregulation of elastase (4.7-fold, P = 0.002), glycoprotein 2 (3.5-fold, P = 0.02) and trypsin (6.0-fold, P = 0.002); n = 4 WT and 4 KO; C: Quantitative real-time
polymerase chain reaction analysis of dx1, Ins1, and Glut2 shows increased expression of these genes in Nkcc1-/- duodenum. Expression levels were normalized
using the L32 ribosomal subunit mRNA; n = 4 WT (black bars) and 4 KO (grey bars). aP < 0.01 vs WT, bP < 0.002 vs WT. Gp2: Glycoprotein 2; Ela: Elastase; Try:
Trypsin; WT: Wild-type; KO: Nkcc1-/-; Pdx1: Pancreatic duodenal homeobox 1; Ins1: Insulin1; Glut2: Glucose transporter type 2.

significance cutoff of P < 0.025, which analyzed the
top 390 genes out of 13551 associated with known GO
categories.
The most statistically significant GO categories
included genes encoding the pancreatic enzymes that
were discussed above, along with genes for additional
peptidases and lipases, most of which are directed at
digestion of food in the intestinal tract (Table 4). Most
of these genes were upregulated; the few that were
modestly down-regulated were peptidases with either
no apparent role in digestion (Otud4, Dpep3, and Hpn)
or that were expressed at very low levels for a digestive
enzyme, such as pepsinogen 5.
The most intriguing changes involved altered exp
ression of receptors involved in chemical sensing (Table
5). These included some G-protein coupled receptors
(GPCRs) that are known to be involved in chemical
[13]
sensing in the intestinal tract, such as Gpbar1 and
[14]
Ffar2 , as well as a large number of G-protein rece
ptors of the olfactory receptor family and several of the
vomeronasal receptor family. As discussed below, this
suggests that the loss of NKCC1 affects chemosensing in
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the intestinal tract, and also suggests that olfactory and
vomeronasal receptors play a major role in this process.

DISCUSSION
The results of this study show that the loss of NKCC1
in small intestine leads to upregulation of digestive
enzymes, many of which are typical of the exocrine
pancreas, and to differential expression of a large
number of genes encoding chemosensing receptors.
As noted in the Introduction, loss-of-function mutations
in the SLC12A2 (NKCC1) gene lead to unexplained
failure of intestinal function/food tolerance (http://
www.genome.gov/27551936). Although it is possible
that impaired secretion contributes to this phenotype,
considerable compensation for loss of NKCC1-mediated
[5,6]
basolateral Cl -uptake occurs in the intestine
and
Cystic Fibrosis patients and mice exhibit a more
profound secretory defect than NKCC1-null mice. This
suggests that factors other than impaired secretion
account for the severe intestinal phenotype in humans
with Nkcc1 mutations.
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Figure 2 Colocalization of peptidases in goblet cells of the duodenum. DAPI (blue) identifies nuclei and TFF3 (intestinal trefoil factor, green fluorescence)
identifies goblet cells. Elastase, amylase and trypsin are identified by red fluorescence. The merged images show colocalization of each of these proteases and TFF3.
Staining patterns were assessed in 4 wild-type and 3 Nkcc1-/- mice. The images shown are for NKCC1-null mice. Control sections with only primary or only secondary
antibodies do not identify goblet cells (not shown).

Figure 3 Amylase is expressed in a subset of goblet cells. Immunofluorescence of amylase (top, red) identifies many, but not all, goblet cells that are clearly
stained with AB/PAS (bottom). The same sections (slides) from NKCC1-null intestine was used for immunofluorescence, imaged, and then stained with AB/PAS.
Arrows indicate the same cell in both images. AB/PAS: Alcian Blue/Periodic Acid-Schiff.

The most striking result of the microarray analyses,
although perhaps of limited clinical importance (dis
cussed below), was the increased expression of digestive
enzymes that are normally expressed at high levels in
the pancreas and the restriction of their expression to
a subset of goblet cells. Because it is critical to prevent
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premature release of digestive enzymes within the
pancreas, many digestive enzymes are produced and
packaged as inactive forms in zymogen granules,
which release the enzymes upon secretion into the
duodenum. Several genes that encode proteins involved
in zymogen granule function (Gp2, Sync, and Pdia2),
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Table 3 Significantly enriched Gene Ontology categories
P -value

GO category
Single ranked list
GO:0008236 Serine-type peptidase activity
GO:0008233 Peptidase activity
GO:0007586 Digestion
GO:0007600 Sensory perception
GO:0006508 Proteolysis
GO:0004984 Olfactory receptor activity
GO:0004806 Triglyceride lipase activity
GO:0004930 GPCR activity
Two unranked lists (target and background)
GO:0008236 Serine-type peptidase activity
GO:0007586 Digestion
GO:0004930 GPCR activity
GO:0004984 Olfactory receptor activity
GO:0004806 Triglyceride lipase activity
GO:0008233 Peptidase activity

Enrichment

(N , B, n , b)

3.38E-14
7.66E-11
1.82E-10
3.45E-8
4.01E-8
7.11E-8
7.01E-7
3.86E-5

35.6
12.6
209.8
1.67
7.65
1.82
271.0
2.41

(13551, 135, 31, 11)
(13551, 451, 31, 13)
(13551, 19, 17, 5)
(13551, 817, 1270, 128)
(13551, 743, 31, 13)
(13551, 552, 1270, 94)
(13551, 10, 15, 3)
(13551, 512, 352, 32)

6.03E-8
5.79E-7
1.30E-5
5.86E-5
1.24E-4
2.71E-4

4.63
12.8
2.24
2.08
13.9
2.08

(13551, 135, 390, 18)
(13551, 19, 390, 7)
(13551, 512, 390, 33)
(13551, 552, 390,3 3)
(13551, 10, 390, 4)
(13551, 451, 390, 27)

GO categories were identified using both the Single rank and Two unranked list options of the GOrilla Gene Ontology program[9]. N is the total number
of genes, B is the total number of genes associated with a specific GO term, n is the number of genes in the target set, b is the number of genes in the
intersection. Enrichment = (b/n)/(B/N). GPCR: G-protein coupled receptor; GO: Gene Ontology.

Table 4 Digestive enzymes and peptidases altered in small intestine of Nkcc1

-/-

Gene symbol

Description

Average intensity

Fold change

Carboxypeptidase A1, pancreatic
Elastase 2
Trypsin 4
Carboxypeptidase B1 (tissue)
Trypsin 10
Chymotrypsin C (caldecrin)
Chymotrypsinogen B
Pancreatic lipase
Protease, serine 1 (trypsin 1)
Carboxyester lipase, pancreatic
Elastase 3B, pancreatic
Trypsin Ⅱ, anionic
Pancreatic lipase related protein 1
Elastase 1, pancreatic
RIKEN cDNA 2210010C04 gene
Chymotrypsin like; chymotrypsin A
Kallikrein 1
Kallikrein 1-related petidase b26
Pancreatic lipase related protein 2
Kallikrein 21
Cytochrome P450 7B1
Prolyl carboxypeptidase (angiotensinase C)
Archaelysin family metallopeptidase 1
OTU domain containing 4
Pepsinogen 5, group Ⅰ
Dipeptidase 3
Serine protease hepsin

1811
2118
2251
866
2306
397
3360
1938
1481
356
1576
716
574
549
125
1431
278
988
833
386
100
566
887
524
168
301
206

15.86
12.05
9.91
9.15
8.33
7.79
7.66
7.24
6.93
6.73
6.69
6.52
5.83
4.84
3.89
3.49
1.82
1.80
1.74
1.66
1.53
1.51
1.35
-1.34
-1.42
-1.48
-1.99

Cpa1
Elane
Try4
Cpb1
Try10
Ctrc
Ctrb1
Pnlip
Prss1
Cel
Cela3b
Prss2
Pnliprp1
Cela1
2210010C04Rik
Ctrl
Klk1
Klk1b26
Pnliprp2
Klk1b21
Cyp7b1
Prcp
Amz1
Otud4
Pga5
Dpep3
Hpn

mice
P -value
0.00001
0.00001
0.00001
0.00001
0.00001
0.0003
0.00001
0.00001
0.00001
0.00001
0.00001
0.0001
0.0001
0.0002
0.0005
0.0030
0.0180
0.0030
0.0181
0.0036
0.0229
0.0047
0.0121
0.0221
0.0198
0.0197
0.0211

Differential expression is presented as fold-changes in Nkcc1-/- intestine relative to wild-type intestine. Average intensity (average of Cy3 and Cy5
fluorescence intensities) is roughly indicative of relative expression levels. P values are less than or equal to the numbers shown.

were upregulated. Glycoprotein 2 is the most abundant
protein on zymogen granules and is thought to regulate
[15]
exocytosis at the apical pole of the granule . Syncollin
is found on the luminal surface of zymogen granules,
and syncollin-deficient mice exhibit impaired exocytosis
[16]
of granules from pancreatic acinar cells . Pancreatic
protein disulfide isomerase plays a major role in forming
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the disulfide linkages of secretory proteins and has
[17]
been localized to zymogen granule membranes .
These expression patterns are consistent with increased
synthesis and packaging of zymogen granule proteins in
-/the Nkcc1 intestine.
During embryonic development, the endoderm
gives rise to the pancreas, liver, and the epithelial
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Table 5 G-protein coupled, olfactory, and vomeronasal receptors
Gene symbol
V1rh10
Olfr846
Olfr491
Olfr419
Olfr827
Olfr992
Olfr506
Olfr812
Gpr63
Olfr1080
V1rh1
Olfr344
Olfr1340
Olfr378
Olfr643
Olfr1000
Olfr1134
Olfr906
Olfr736
Olfr433
Olfr78
Olfr90
Prokr1
Olfr1494
Olfr1462
Olfr444
Nmur1
Olfr1366
Olfr804
Gpbar1
Gprc5a
Olfr740
Olfr1156
Rxfp4
Igf2r
Olfr641
Olfr48
Vmn1r210
Grm2
Vmn1r5
Ffar2

Description

Average intensity

Fold change

P -value

Vomeronasal 1 receptor, H10
Olfactory receptor 846
Olfactory receptor 491
Olfactory receptor 419
Olfactory receptor 827
Olfactory receptor 992
Olfactory receptor 506
Olfactory receptor 812
G protein-coupled receptor 63
Olfactory receptor 1080
Vomeronasal 1 receptor, H2
Olfactory receptor 344
Olfactory receptor 1340
Olfactory receptor 378
Olfactory receptor 643
Olfactory receptor 996
Olfactory receptor 1134
Olfactory receptor 906
Olfactory receptor 736
Olfactory receptor 433
Olfactory receptor 78
Olfactory receptor 90
Prokineticin receptor 1
Olfactory receptor 1494
Olfactory receptor 1462
Olfactory receptor 444
Neuromedin U receptor 1
Olfactory receptor 1366
Olfactory receptor 804
G protein-coupled bile acid receptor 1
G protein-coupled receptor, C5A
Olfactory receptor 739
Olfactory receptor 152
Relaxin family peptide receptor 4
Insulin-like growth factor 2 receptor
Olfactory receptor 641
Olfactory receptor 140
Vomeronasal 1 receptor 210
Glutamate receptor, metabotropic 2
Vomeronasal 1 receptor 5
Free fatty acid receptor 2

107
432
79
477
122
300
143
53
42
66
60
50
79
67
77
475
139
134
92
189
125
106
196
457
260
252
196
89
404
129
936
172
156
397
1089
652
99
192
179
124
203

4.66
3.66
3.18
3.12
2.65
2.53
2.48
2.37
2.08
1.90
1.88
1.87
1.83
1.81
1.72
1.72
1.71
1.68
1.67
1.65
1.62
1.56
1.56
1.54
1.52
1.52
1.51
1.50
1.48
1.47
1.46
1.43
1.43
1.37
-1.39
-1.39
-1.48
-1.54
-1.63
-1.64
-1.85

0.0008
0.0001
0.0051
0.0004
0.0001
0.0005
0.0049
0.0048
0.0023
0.0107
0.0071
0.0057
0.0123
0.0072
0.0080
0.0127
0.0101
0.0038
0.0166
0.0039
0.0087
0.0235
0.0096
0.0180
0.0183
0.0154
0.0177
0.0207
0.0175
0.0216
0.0142
0.0164
0.0211
0.0132
0.0158
0.0211
0.0143
0.0127
0.0028
0.0071
0.0092

Differential expression is presented as fold-changes in Nkcc1-/- intestine relative to wild-type intestine. Average intensity (average of Cy3 and Cy5
fluorescence intensities) is roughly indicative of relative expression levels. P values are less than or equal to the numbers shown.

lining of the gastrointestinal tract. This requires the
expression of various transcription factors, as well as
interactions between the epithelium and surrounding
[18,19]
mesenchyme
. It has become clear that the relative
plasticity of the pancreas, liver, and intestine is high,
and that certain populations of cells within these organs
can undergo transdifferentiation. Although this initially
seemed to be an interesting possibility, it is unlikely that
-/transdifferentiation is occurring in the Nkcc1 small
intestine. Several transcription factors, including Pdx1
and pancreas transcription factor 1 (Ptf1a) have been
shown to mediate plasticity between the pancreas and
small intestine. Expression of Pdx1 is a key regulatory
step in the development of both the pancreas and the
[20]
duodenum , and inactivation of Ptf1a drives pancreatic
[21]
precursor cells toward intestinal cell fates . Although
expression of pancreatic genes was upregulated, Pdx1
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was only modestly increased and expression of Ptf1a
was not changed (data not shown). Furthermore,
when we examined relative expression levels of the
pancreatic enzymes in human pancreas and duodenum
that are available through the EBI Expression Atlas (see
methods) it was clear that the pancreatic enzymes are
expressed at several orders of magnitude higher levels
in pancreas than in duodenum. Thus, the apparently
-/robust expression of pancreatic enzymes in the Nkcc1
intestine is likely to be far below the levels of expression
occurring in the pancreas. Similarly, although insulin
-/(Ins1) was mildly induced in Nkcc1 intestine, the EBI
expression Atlas data indicates that insulin expression in
human pancreas is far greater than that in duodenum
(relative transcript levels 551 in pancreas vs 0.3 in
duodenum). Although we obtained an antibody against
human insulin, which readily and specifically identified
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pancreatic islet cells in the mouse (data not shown),
-/we were unable to detect insulin in Nkcc1 intestine,
consistent with exceedingly low levels of expression.
The reason for the increased expression of pan
creatic enzymes in goblet cells is unclear. Histological
analyses gave no evidence for an increase in goblet
-/cells in Nkcc1 intestine, and the expression levels of
Tff3 (intestinal trefoil factor) and Muc2 (mucin 2), which
are expressed at very high levels in goblet cells, were
not significantly changed. However, NKCC1 has been
shown to be expressed at high levels on basolateral
[1]
membranes of goblet cells , and there is evidence
[22]
that it affects mucous secretion . Thus, it is possible
that the absence of NKCC1 specifically in goblet cells
has a direct effect on the expression of pancreatic enzy
mes. Whether this is due to subtle effects of NKCC1deficiency on the differentiation of goblet cells is unclear.
Despite the changes in mRNA expression patterns
-/between the WT and Nkcc1 intestine, previous
studies of two different NKCC1 knockouts revealed
no significant histological changes between the two
[3,4]
genotypes in the adult intestine
. Furthermore,
detailed morphometric analyses of the intestinal tracts
-/of 8-wk-old WT and Nkcc1 mice, the same age as used
in the current study, revealed no significant differences
[3]
in cell structure . We cannot, of course, rule out subtle
changes in cell differentiation resulting from changes
during early development or during regular turnover
of the epithelium. However, the normal epithelial cell
structure and relatively modest changes in expression
of two of the major transcription factors involved in
development of the pancreas and intestine, argue
against defects in development and/or epithelial cell
differentiation as the basis of the observed expression
changes. Also, as discussed below, NKCC1 serves a
direct role in the process of chemical sensing in olfactory
neurons, suggesting that the changes in expression
of chemosensing receptors is a direct response to
the absence NKCC1 rather than being secondary to
developmental defects.
Although less dramatic than the changes in pancre
atic genes, the significant changes in expression of
a large number of G-protein coupled chemosensing
receptors suggest that the loss of NKCC1 may cause
major impairments in the sensing of nutrients and other
constituents of the intestinal contents. It is clear from
many studies that GPCRs play a major role in intestinal
[23]
chemosensing . In fact, some of the GPCRs identified as
differentially expressed in our microarray analyses have
been shown to play important roles in chemosensing
in the gut. Gpbar1 (1.47-fold increase) is expressed in
enteroendocrine L-cells, where it senses bile acids and
transduces a signal that leads to secretion of glucagonlike peptide 1 (GLP-1) and peptide tyrosine-tyrosine,
[13,24]
thereby regulating glucose homeostasis
. Ffar2
(-1.85-fold decrease) is expressed in enteroendocrine
[14]
cells and serves as a sensor of short-chain fatty acids .
Gpr63 (2.1-fold increase), which was expressed at
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relatively low levels, has been identified as a receptor for
[25]
several lipids, including N-Arachidonylethanolamine
and both sphingosine 1-phosphate and dioleoylp
[26]
hasphatidic acid . Grm2 (-1.63-fold decrease) is one of
the metabotropic glutamate receptors that is involved in
[27]
nutrient sensing through taste receptors . Several of
the differentially expressed GPCRs serve as receptors for
peptide hormones that affect gut function. These include
Rxfp4 (1.37-fold increase), which is the receptor for the
[28]
orexigenic (appetite-stimulating) insulin-like peptide 5 ,
and Nmur1 (1.51-fold increase), which is a receptor for
neuromedin U and functions in glucose and appetite
[29]
homeostasis .
The GPCRs that are known to play major roles in
chemical sensing include taste receptors, olfactory
receptors, and volmeronasal receptors. Taste receptors
are known to function in the intestinal tract and to
play major roles in nutrient sensing and subsequent
[27,30-32]
signaling events
. There is less information about
the role of olfactory receptors in chemosensing in the
intestinal tract, but recent evidence indicates that olfa
ctory receptors are expressed on colonic epithelial
tissues, where they may detect bacterial metabolites in
[33]
the luminal contents . In addition, specific olfactory
receptors have been shown to be differentially expressed
in the duodenum of obesity-prone rats fed a high-fat
[34]
diet . The authors speculated that these receptors
may be involved in sensing and responding to dietary
fat. Specific olfactory receptors have also been identified
in human enterochromaffin cells and when stimulated
[35,36]
can lead to the release of serotonin
. Vomeronasal
[37]
receptors also function in chemosensing , but as
far as we are aware there is no previous evidence for
their expression and function in the intestinal tract.
Nevertheless, V1rh10 was the most highly upregulated
gene among the G-protein coupled receptors (4.66-fold),
indicating that it’s expression is responsive to the loss of
NKCC1.
Previous studies have shown that NKCC1 plays an
important role in signaling through olfactory receptors.
Odorant-induced Cl currents, which are required
for signaling, were reduced in olfactory neurons of
-/[38]
Nkcc1 mice , indicating that NKCC1 is an important
mechanism for Cl -uptake in olfactory neurons.
However, later studies provided strong evidence for
additional Cl -loading mechanisms that can provide
[39,40]
some compensation for the loss of NKCC1
, and
-/physiological studies indicated that WT and Nkcc1 mice
[41]
have similar sensitivities to several specific odorants .
In more recent studies, however, loss of NKCC1
caused defects in the sensitivity to a complex mixture
-/of odorants, and RNA Seq analysis of WT and Nkcc1
olfactory epithelium revealed significant differential
expression changes involving a large number of olfactory
[42]
receptors . Thus, loss of NKCC1 leads to differential
expression changes involving chemosensing receptors
[42]
in both the olfactory epithelium
and in the small
intestine, as indicated in the current study.

147

February 15, 2016|Volume 7|Issue 1|

Bradford EM et al . Expression changes in NKCC1-null intestine

Peer-review

-/-

In summary, the microarray analysis of Nkcc1
small intestine indicates that the loss of NKCC1 leads
both to increased expression of pancreatic enzymes in
a subset of goblet cells and to differential expression
of chemosensing GPCRs, including a large number of
olfactory receptors. Because a number of GPCRs with
well-established roles in chemosensing in the intestine
were among the receptors that were changed, it
seems likely that the differential expression of olfactory
receptors is also indicative of altered sensing of com
ponents of the luminal contents. This finding raises the
possibility that the episodic hypoglycemia and failure of
intestinal function/food tolerance observed in human
patients with NKCC1 (SLC12A2 gene) mutations may
be due to chronic deficiencies in their ability to properly
sense and respond to nutrients and other constituents of
the intestinal lumen. Finally, it should also be noted that
loop diuretics that inhibit NKCC1 have been associated
with an increased incidence of intestinal dysfunction,
[43]
including constipation
and indications of a poor
[44]
outcome following ischemic colitis . It is therefore
possible that inhibition of NKCC1 by these common
therapeutic agents could lead to intestinal dysfunction
similar to that observed in NKCC1 genetic deficiencies.
Whether this is due to developmental abnormalities
involving one or more cell types in the intestinal epit
helium and/or is a more direct response to impaired
chemosensing is unclear.

This study aimed to analyze the mRNA expression changes in the intestine
of NKCC1-/- mice. The methods of this study, methods were properly used to
identify cell types, and results were also presented clearly.
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